After Tense Fights, An FDA Panel Said Pfizer Boosters Should Go To Older Adults And Others At High Risk

3 years ago

The advisory panel of outside health experts recommended that a third dose of the Pfizer vaccine be authorized for people over 65 and those at high risk, rejecting the benefit for the general population.

View Entire Post ›

Read Entire Article